Cantabio Pharmaceuticals Inc.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2017)
- -$2.0M
- Total Assets (FY2017)
- $109.4K
- Total Equity (FY2017)
- -$1.9M
- Cash Flows from Operating Activities (FY2017)
- -$623.3K
Source: Cantabio Pharmaceuticals Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
